COVID-19 Identified as Trigger for aHUS in 2 Adults, Case Study Shows
COVID-19 was identified as the trigger for atypical hemolytic uremic syndrome (aHUS) in two adults, but the patients — one man and one woman — responded well to treatment with Soliris (eculizumab), according to a recent study. The study, “Case series: coronavirus disease 2019 infection as a…